The pathogenesis of autosomal dominant polycystic kidney disease: An update

Current Opinion in Nephrology and Hypertension

Volumn 9, Issue 4, 2000, Pages 385-394

  Somlo, Stefan ^a   Markowitz, Glen S ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

POLYCYSTIN;

AUTOSOMAL DOMINANT INHERITANCE; FRAMESHIFT MUTATION; HUMAN; KIDNEY POLYCYSTIC DISEASE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; STRUCTURE ANALYSIS;

ANIMALS; CALCIUM CHANNELS; HUMANS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PROTEINS; TRPP CATION CHANNELS;

EID: 0033935562     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200007000-00010     Document Type: Review

References (69)

1. 1 USRDS. USRDS 1999 Annual Data Report, 1998.
2. 2 The European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14kb transcript and lies within a duplicated region on chromosme 16. Cell 1994; 77:881-894.
3. 3 The American PKD1 Consortium. Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease gene (PKD1) predicts the presence of a leucine-rich repeat. Hum Molec Genet 1995; 4:575-582.
4. 4 The International Polycystic Kidney Disease Consortium Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 1995; 81:289-298.
5. 5 Mochizuki T, Wu G, Hayashi T, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996; 272:1339-1342.
6. 6 Watnick T, Germino GG. Molecular basis of autosomal dominant polycystic kidney disease. Semin Nephrol 1999; 19:327-343.
7. 7 van Adelsberg JS. The role of the polycystins in kidney development. Pediatr Nephrol 1999; 13:454-459.
8. 8 Avner ED, Woychik RP, Dell KM, Sweeney WE. Cellular pathophysiology of cystic kidney disease: insight into future therapies. Int J Dev Biol 1999; 43:457-461.
9. 9 Wilson PD, Burrow CR. Cystic diseases of the kidney: role of adhesion molecules in normal and abnormal tubulogenesis. Exp Nephrol 1999; 7:114-124.
10. 10 Wu G, Somlo S. Molecular genetics and mechanism of autosomal dominant polycystic kidney disease. Mol Genet Metab 2000; 69:1-15.
11. 11 Torres VE. New insights into polycystic kidney disease and its treatment. Curr Opin Nephrol Hypertens 1998; 7:159-169.
12. 12 Qian F, Watnick TJ, Onuchic LF, Germino GG. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 1996; 87:979-987.
13. 13 Brasier JL, Henske EP. Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis. J Clin Invest 1997; 99:194-199.
14. 14 Watnick TJ, Torres VE, Gandolph MA, et al. Somatic mutation in individual liver cysts supports a two-hit model of cystogenesis in autosomal dominant polycystic kidney disease. Mol Cell 1998; 2:247-251.
15. 15 Wu G, D'Agati V, Cai Y, et al. Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 1998; 93:177-188.
16. 16 Koptides M, Hadjimichael C, Koupepidou P, et al. Germinal and somatic mutations in the PKD2 gene of renal cysts in autosomal dominant polycystic kidney disease. Hum Mol Genet 1999; 8:509-513.
17. 17 Pei Y, Watnick T, He N, et al. Somatic PKD2 mutations in individual kidney and liver cysts support a 'two-hit' model of cystogenesis in type 2 autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1999; 10:1524-1529.
18. 18 Torra R, Badenas C, San Millan JL, et al. A loss-of-function model for cystogenesis in human autosomal dominant polycystic kidney disease type 2. Am J Hum Genet 1999, 65:345-352.
19. 19 Ong AC, Harris PC, Davies DR, et al. Polycystin-1 expression in PKD1, early-onset PKD1, and TSC2/PKD1 cystic tissue. Kidney Int 1999; 56:1324-1333. A tissue staining study suggesting that if second hits occur in ADPKD, many must be missense variants. This creates a testable hypothesis as more second hits and germline mutations in the region of PKD1 heretofore inaccessible due to genomic complexity are discovered.
20. 20 Koptides M, Mean R, Demetriou K, et al. Genetic evidence for a trans-heterozygous model for cystogenesis in autosomal dominant polycystic kidney disease. Hum Mol Genet 2000; 9:447-452. First study showing the possibility that cyst formation in ADPKD can occur by compound trans-heterozygote mechanism with germline mutation in PKD1 and second hit in PKD2.
21. 21 Loftus BJ, Kim UJ, Sneddon VP, et al. Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. Genomics 1999; 60:295-308.
22. 22 Watnick T, Phakdeekitcharoen B, Johnson A, et al. Mutation detection of PKD1 identifies a novel mutation common to three families with aneurysms and/or very-early-onset disease. Am J Hum Genet 1999; 65:1561-1571. An important study for two reasons. First, due to the improved methodology for mutation detection in the reduplicated portion of PKD1, and second because common germline mutation with severe phenotype suggests the possibility of genotype/phenotype correlation, perhaps based on effects of partial protein product.
23. 23 Thomas R, McConnell R, Whittacker J, et al. Identification of mutations in the repeated part of the autosomal dominant polycystic kidney disease type 1 gene, PKD1, by long-range PCR. Am J Hum Genet 1999; 65:39-49. This study shows feasibility and methodology for mutation detection in reduplicated region of PKD1.
24. 24 Blaszak RT, Potaman V, Sinden RR, Bissler JJ. DNA structural transitions within the PKD1 gene. Nucleic Acids Res 1999; 27:2610-2617.
25. 25 Piontek KB, Germino GG. Murine Pkd1 introns 21 and 22 lack the extreme polypyrimidine bias present in human PKD1. Mamm Genome 1999; 10:194-196.
26. 26 Paterson AD, Pei Y. Is there a third gene for autosomal dominant polycystic kidney disease? Kidney Int 1998; 54:1759-1761.
27. 27 Paterson AD, Pei Y. PKD3-to be or not to be? Nephrol Dial Transplant 1999; 14:2965-2966.
28. 28 Hateboer N, Lazarou LP, Williams AJ, et al. Familial phenotype differences in PKD1. Kidney Int 1999; 56:34-40. A comprehensive comparison of clinical course in type 1 and type 2 ADPKD. Major findings include the following: that hypertension is a markedly less frequent complication in PKD2 than PKD1, PKD2 is significantly less severe in women but that this is not the case for PKD1, the late age in diagnosis in PKD2 confirms the possibility of under-ascertainment, there may be a decrease in survival in PKD2 that is independent of renal complications.
29. 29 Reynolds DM, Hayashi T, Cai Y, et al. Aberrant splicing in the PKD2 gene as a cause of polycysitic kidney disease. J Am Soc Nephrol 1999; 10:2342-2351. Two major points from this paper are that genomic mutation detection without confirmation at the level of the gene transcript can be deceptive,and lymphoblasts from PKD2-affected individuals express half normal levels of polycystin-2 (potential of diagnostic use).
30. 30 Aguiari G, Manzati E, Penolazzi L, et al. Mutations in autosomal dominant polycystic kidney disease 2 gene: reduced expression of PKD2 protein in lymphoblastoid cells. Am J Kidney Dis 1999; 33:880-885.
31. 31 Geng L, Segal Y, Peissel B, et al. Identification and localization of polycystin, the PKD1 gene product. J Clin Invest 1996; 98:2674-2682.
32. 32 Geng L, Segal Y, Pavlova A, et al. Distribution and developmentally regulated expression of murine polycystin. Am J Physiol 1997; 272:F451-F459.
33. 33 van Adelsberg J, Chamberlain S, D'Agati V. Polycystin expression is temporally and spatially regulated during renal development. Am J Physiol 1997; 272:F602-F609.
34. 34 Guillaume R, D'Agati V, Daoust M, Trudel M. Murine Pkd1 is a developmentally regulated gene from morula to adulthood: role in tissue condensation and patterning. Dev Dyn 1999; 214:337-348. This is the only published study using in situ hybridization of Pkd1 in mouse development. It is carefully done and highly informative.
35. 35 Peters DJ, van de WA, Spruit L, et al. Cellular localization and tissue distribution of polycystin-1. J Pathol 1999; 188:439-446.
36. 36 Huan Y, van Adelsberg J. Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins. J Clin Invest 1999; 104:1459-1468. A study that suggests a role for polycystin-1 in cell signaling complexes.
37. 37 Markowitz GS, Cai Y, Li L, et al. Polycystin-2 expression is developmentally regulated. Am J Physiol 1999; 277:F17-F25. The first description of immunolocalization of polycystin-2 in mouse development. It shows the existence of developmental regulation and serves as a significant adjunct to mouse knockout studies.
38. 38 Obermuller N, Gallagher AR, Cai Y, et al. The rat Pkd2 protein assumes distinct subcellular distributions in different organs. Am J Physiol 1999; 277:F914-F925. This first immunolocalization of polycystin-2 in adult rat tissues suggests differential subcellular distributions in different tissues. It raises the possibility that polycystin-2 has different functions in different cell types and that binding partners will likely also be tissue specific.
39. 39 Ong AC, Ward CJ, Butler RJ, et al. Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue. Am J Pathol 1999; 154:1721-1729.
40. 40 Cai Y, Maeda Y, Cedzich A, et al. Identification and characterization of polycystin-2, the PKD2 gene product. J Biol Chem 1999; 274:28557-28565. The authors established that polycystin-2 is expressed in the endoplasmic reticulum of cells in culture. Furthermore, the study identifies a 34 amino acid stretch in cytoplasmic tail that is essential to this localization. In light of the putative interaction of polycystin-1 and -2, this work raises the possibility that polycystin-1 or another binding partner is required to relocalize polycystin-2 to the plasma membrane or that PKD1 and PKD2 interact across separate membranes.
41. 41 Qian F, Germino FJ, Cai Y, et al. PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat Genet 1997; 16:179-183.
42. 42 Tsiokas L, Kim E, Arnould T, et al. Homo-and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc Natl Acad Sci U S A 1997; 94:6965-6970.
43. 43 Emmons SW, Somlo S. Mating, channels and kidney cysts. Nature 1999; 401:339-340.
44. 44 Moy GW, Mendoza LM, Schulz JR, et al. The sea urchin sperm receptor for egg jelly is a modular protein with extensive homology to the human polycystic kidney disease protein, PKD1. J Cell Biol 1996; 133:809-817.
45. 45 Hughes J, Ward CJ, Aspinwall R, et al. Identification of a human homologue of the sea urchin receptor for egg jelly: a polycystic kidney disease-like protein. Hum Mol Genet 1999; 8:543-549. Cloning of the human homologue of the sea urchin sperm egg jelly receptor, which is highly related to polycystin-1 and may have assayable function in mammalian species.
46. 46 Barr MM, Sternberg PW. A polycystic kidney disease gene homolog required for male mating behavior in Caenorhabiditis elegans. Nature 1999; 401:386-389. The C. elegans homologue of polycystin-1 is a mechano-or chemosensory signal transducer that co-localizes with PKD-2. Powerful C. elegans genetics should allow ready identification of additional players in this signaling pathway and provides ready in-vivo assay.
47. 47 Nomura H, Turco AE, Pei Y, et al. Identification of PKDL, a novel polycystic kidney disease 2-like gene whose murine homologue is deleted in mice with kidney and retinal defects. J Biol Chem 1998; 273:25967-25973. A study involving the cloning of a gene closely related to PKD2. The homologue is mapped to the deleted interval in the kidney-retinal defects mouse.
48. 48 Wu GQ, Hayashi T, Park JH, et al. Identification of the human PKD2-related cDNA, PKD2L: tissue-specific expression and linkage mapping on chromosome 10q25. Genomics 1998; 54:564-568. Partial cloning of a PKD2 homolgue (same as [47]) showing tissue restricted pattern of expression and evidence for alternative splicing.
49. 49 Veldhuisen B, Spruit L, Dauwerse HG, et al. Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2). Eur J Hum Genet 1999; 7:860-872. Cloning of a second homologue of PKD2 is outlined, this one possibly restricted to testis. It may work with the PKD1 homologue in [45].
50. 50 Guo L, Chen M, Basora N, Zhou J. The human polycystic kidney disease 2-like (PKDL) gene: exon/intron structure and evidence for a novel splicing mechanism. Mamm Genome 2000; 11:46-50.
51. 51 Chen XZ, Vassilev PM, Basora N, et al. Polycystin-L is a calcium-regulated cation channel permeable to calcium ions. Nature 1999; 401:383-386. A demonstration that the PKD2 homologue in [47] and [48] acts as a calcium regulated cation channel. Strongest evidence to date, albeit indirect, the polycystin-2 can also be a channel subunit.
52. 52 Tsiokas L, Arnould T, Zhu C, et al. Specific association of the gene product of PKD2 with the TRPC1 channel. Proc Natl Acad Sci U S A 1999; 96:3934-3939. A transient receptor potential channel subunit interacts with polycystin-2. This provides a potential experimental system for testing polycystin function, although no functional data are presented.
53. 53 Kim E, Arnould T, Sellin L, et al. Interaction between RGS7 and polycystin. Proc Natl Acad Sci U S A 1999; 96:6371-6376. A yeast two hybrid screen discovered interaction between the cytoplasmic tail of polycystin-1 and a putative regulator of G protein signaling.
54. 54 Arnould T, Kim E, Tsiokas L, et al. The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1. J Biol Chem 1998; 273:6013-6018.
55. 55 Wilson PD, Geng L, Li X, Burrow CR. The PKD1 gene product, 'polycystin-1' is a tyrosine-phosphorylated protein that colocalizes with alpha2beta1-integrin in focal clusters in adherent renal epithelia. Lab Invest 1999; 79:1311-1323. A study suggesting the possibility of tyrosine phoshphorylation of polycystin-1 and association with integrin complex.
56. 56 Arnould T, Sellin L, Benzing T, et al. Cellular activation triggered by the autosomal dominant polycystic kidney disease gene product PKD2. Mol Cell Biol 1999; 19:3423-3434. Polycystin-2 may have a role in AP-1 mediated transcription. The same has been found for polycsytin-1.
57. 57 Parnell SC, Magenheimer BS, Maser RL, Calvet JP. Identification of the major site of in vitro PKA phosphorylation in the polycystin-1 C-terminal cytosolic domain. Biochem Biophys Res Commun 1999; 259:539-543.
58. 58 Li HP, Geng L, Burrow CR, Wilson PD. Identification of phosphorylation sites in the PKD1-encoded protein C-terminal domain. Biochem Biophys Res Commun 1999; 259:356-363.
59. 59 Bycroft M, Bateman A, Clarke J, et al. The structure of a PKD domain from polycystin-1: implications for polycystic kidney disease. EMBO J. 1999; 18:297-305. A solution structure using nuclear magnetic resonance spectroscopy for one of the extracellular PKD repeat domains: it forms a β-sandwich fold. Domain 10 is thought to be the most conserved and will likely be the focus of attempts at ligand discovery.
60. 60 van Adelsberg J. Peptides from the PKD repeats of polycystin, the PKD1 gene product, modulate pattern formation in the developing kidney. Dev Genet 1999; 24:299-308. This innovative study assesses the effects of exogenously applied PKD domain related peptides on branching morphogenesis of kidney rudiment explants.
61. +/ mice also have decreased survival despite absence of renal failure.
62. 62 Richards WG, Sweeney WE, Yoder BK, et al. Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease. J Clin Invest 1998; 101:935-939.
63. 63 Sweeney WE, Chen Y, Nakanishi K, et al. Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. Kidney Int 2000; 57:33-40. Treatment of bpk mice (model of recessive polycystic kidney disease) with a tyrosine kinase inhibitor results in improved renal cystic disease and survival, presumably through anti-proliferative effect.
64. +/ background, which increases apoptosis.
65. 65 Bankovic-Calic N, Eddy A, Sareen S, Ogborn MR. Renal remodelling in dietary protein modified rat polycystic kidney disease. Pediatr Nephrol 1999; 13:567-570.
66. 66 Ogborn MR, Nitschmann E, Weiler H, et al. Flaxseed ameliorates interstitial nephritis in rat polycystic kidney disease. Kidney Int 1999; 55:417-423.
67. 67 Ogborn MR, Nitschmann E, Weiler HA, Bankovic-Calic N. Modification of polycystic kidney disease and fatty acid status by soy protein diet. Kidney Int 2000; 57:159-166.
68. 68 Lu W, Peissel B, Babakhanlou H, et al. Perinatal lethality with kidney and pancreas defects in mice with a targeted Pkd1 mutation. Nat Genet 1997; 17:179-181.
69. 69 Kim K, Drummond I, Ibraghimov-Beskrovnaya O, et al. Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci U S A 2000; 97:1731-1736. A Pkd1 mutant mouse model that describes a structural vascular phenotype.